Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Child Opportunity Index and Child Health: Evolving Evidence and Interventions

2 months 1 week ago
No abstract
Megan M Attridge

Cross-resistance-guided phage cocktail design for effective mitigation of necrotic enteritis in poultry

2 months 1 week ago
The withdrawal of antibiotic growth promoters from poultry production has led to the resurgence of Clostridium perfringens-induced necrotic enteritis (NE), resulting in annual global economic losses exceeding $6 billion. With conventional antibiotics becoming less accessible for disease prevention, there is an urgent need for effective non-antibiotic alternatives. Bacteriophage therapy represents a promising approach, although its utility is often constrained by narrow host range and rapid...
Eunbyeol Ahn

Evaluating mortality burden of diabetes mellitus and peripheral arterial disease in the United States: insights from 26 years of national data

2 months ago
CONCLUSIONS: Despite overall reductions in mortality, disparities by sex, race/ethnicity, and geography persist. The objective of this study was to explicitly assess long-term mortality trends and demographic disparities associated with DM and PAD in the United States, providing evidence to guide future preventive and policy measures. These results underscore the importance of targeted and equity-driven health interventions to reduce the burden of DM and PAD nationwide.
Ghazi Uddin Ahmed

Systematic Review of Pharmacologic Treatments for Hypochloremic Metabolic Alkalosis in Critically Ill Children

2 months ago
Metabolic alkalosis, characterized by an increase in serum bicarbonate (>28 mEq/L) and serum pH (>7.45), is associated with clinical complications including arrhythmias, mental confusion, and seizures. Non-pharmacologic measures are recommended first-line for treatment of hypochloremic metabolic alkalosis, but pharmacologic treatment may be needed. This review of the literature provides detailed descriptions of dosage regimens, efficacy, safety, and other considerations for use of pharmacologic...
Taylor McLarty

Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: Results of the DT-real study

2 months ago
CONCLUSIONS: STRIDE shows reproducible effectiveness and an acceptable safety profile in real-world practice. Achieving disease control and maintaining liver function emerged as key determinants of long-term survival benefit.
Ciro Celsa

Pagination

  • Previous page ‹ Previous
  • Page 82
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies